What is Healnet?
The realm of rare diseases frequently suffers from inadequate research, leading to a lack of vital insights necessary for successful drug discovery efforts. Our advanced AI platform, Healnet, tackles these challenges by analyzing extensive datasets related to drugs and diseases, revealing novel connections that could pave the way for new treatment options. By employing state-of-the-art technologies during both the discovery and development stages, we can manage several phases at once and on a considerable scale. The traditional methodology, which usually concentrates on one disease, target, and drug, is an overly simplistic model that many pharmaceutical companies continue to follow. The upcoming era of drug discovery is set to be revolutionized by AI, which emphasizes concurrent operations and a flexibility that allows for exploration beyond rigid hypotheses, effectively merging the three fundamental aspects of drug discovery into a unified approach. This innovative framework not only boosts productivity but also encourages inventive thinking in addressing intricate health issues. As we move forward, the integration of AI in drug development will likely reshape how the industry approaches the challenges of rare diseases.
Integrations
No integrations listed.
Similar Software to Healnet
FrameworkLTC offers a comprehensive and adaptable platform that streamlines all manual processes, enabling LTC pharmacies to concentrate on their primary goal: enhancing patient well-being. By transitioning from manual operations to automation, businesses can grow while optimizing their profit margins. Tailoring services to meet the unique requirements of each facility can also enhance partnerships. Our software, designed with a facility-focused approach, empowers you to deliver exceptional service to every patient, section, and establishment. Facilities can easily manage billing, track order statuses, and handle returns based on your established protocols. Your facilities will find great value in the insightful reports you provide. Additionally, automate the prescription refill and reorder process to ensure nothing is overlooked during production. By leveraging this technology, you can significantly improve operational efficiency and patient satisfaction.
Learn more
JDisc Discovery serves as a robust solution for IT asset management and network discovery, offering organizations valuable, real-time visibility into their complete IT landscape. By conducting automated network scans, it efficiently detects and organizes a variety of devices, which ranges from physical servers and workstations to virtual machines and network appliances, thus providing users with a comprehensive asset inventory. The tool meticulously gathers crucial information, encompassing hardware specifications, installed software, system configurations, and the interrelationships among devices, ensuring thorough documentation of the IT environment.
One of the standout features of JDisc Discovery is its agentless design. Instead of requiring software installation on each device, it utilizes multiple protocols such as SNMP, SSH, and WMI to collect data, facilitating rapid deployment and ensuring compatibility across an array of operating systems, including Windows, Linux, and Unix. This adaptability makes it particularly well-suited for varied and evolving IT infrastructures, allowing for effective and unobtrusive data acquisition. Additionally, its user-friendly interface enhances the overall management experience, empowering IT teams to make informed decisions based on accurate and up-to-date information.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more
Recursion
Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.
Learn more
Screenshots and Video
Company Facts
Company Name:
Healx
Date Founded:
2014
Company Location:
United Kingdom
Company Website:
healx.io/technology/
Product Details
Deployment
SaaS
Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English